News

The NIAID director offered nuanced advice on kids going back to school, getting to a baseline in the US, and how to prepare for the upcoming influenza season combined with COVID-19.

A discussion between providers on 3 studies related to the antiviral.

There is mixed international evidence about whether returning to school results in increased transmission or outbreaks, authors explained, and surges may be multiply determined.

Organizations believe the CDC is best positioned to collect, analyze and distribute information that is vital to research and response efforts.

Although plasma levels of lopinavir increase as its metabolism is inhibited by inflammation in COVID-19, levels in the lungs remain subtherapeutic.

A small study reports no mother-to-newborn transmission of virus.

Angela Rasmussen, PhD, explains how preliminary findings for both candidates define their potential for preventing or lessening coronavirus.

Some ways of decontaminating N-95 respirator masks can degrade mask integrity, according to the authors of a recent study.

A benefit–risk analysis of health benefits versus excess risk of SARS-CoV-2 infection

More COVID-19 patients were hospitalized with MIS-C in April than in March, a study finds.

Dr. Pol Vandenbroucke describes the individual and collective risks associated with rising antibiotic resistance.

Dr. Pol Vandenbroucke talks about what makes antibiotic stewardship so important to clinicians and researchers.

In this second installment of his interview, Howard Koh, MD, MPH, discusses the importance of providers and health care workers wearing face masks during their interactions with patients.

HHS is securing Pfizer and BioNTech’s BNT162 vaccine as soon as FDA approves.

Shingles vaccination rates have risen from 6.7% in 2008 to 34.5% in 2018 among American adults 60 and older.

Many families fell behind on vaccines during the pandemic, but a study finds most clinics are available to schedule make-up appointments.

How might this new outbreak in Mbandaka differ from the recent outbreak in Kivu, a more conflict-prone region of the DRC?

The test is not FDA approved, but is instead authorized for emergency use in the context of the SARS-CoV-2 pandemic.

A common combination of probiotics showed no benefits for reducing antibiotic administration in older adults in care homes, according to a study led by Oxford University investigators.

A former Assistant Secretary of Health calls upon both to consider how a face mask mandate could mitigate transmission and mortality.

Dr. Pol Vandenbroucke explains how the development of health and civil society infrastructure around the world helps to slow antimicrobial resistance.

Should we be reconsidering the length of time patients are isolated?

Dr. Pol Vandenbroucke describes the alarming global threat of antimicrobial resistance.

The FDA clears way for next phase for abivertinib to treat hospitalized patients.

A single injection of the Ad5-vectored COVID-19 vaccine induced specific immune responses to the spike glycoprotein at day 28.

This was seen in patients who were receiving either invasive mechanical ventilation or oxygen.

The development of BNT162 is based on BioNTech’s mRNA platform; the vaccine will then be produced using Pfizer’s vaccine manufacturing capacities.

New data shows the ChAdOx1 nCoV-19 vaccine candidate induces T cell response within 14 days, and antibody response within 28 days.